Robert Olstein Charles River Laboratories International, Inc. Transaction History

Olstein Capital Management, L.P.

  • $562 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 04, 2018
SELL
$98.19 - $115.2 $4.74 Million - $5.56 Million
-48,235 Closed
0 $0
Q4 2017

Feb 08, 2018
SELL
$100.43 - $118.09 $1.19 Million - $1.4 Million
-11,877 Reduced 19.76%
48,235 $5.28 Million
Q3 2017

Nov 08, 2017
BUY
$96.72 - $109.26 $5.81 Million - $6.57 Million
60,112
60,112 $6.49 Million

Others Institutions Holding CRL

# of Institutions
732
Shares Held
51.8M
Call Options Held
233K
Put Options Held
236K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track Robert Olstein's Portfolio

Track Robert Olstein Portfolio

Follow Robert Olstein (Olstein Capital Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Olstein Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Olstein Capital Management, L.P. and Robert Olstein with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email